|
|
|
| Clinical effect of Polyethylene Glycol Eye Drops combined with Recombinant Bovine Basic Fibroblast Growth Factor Eye Gel in the treatment of meibomian gland dysfunction xerophthalmia |
| KANG Bin WAN Jin-lan▲ |
| Department of Ophthalmology,Jingmen Traditional Chinese Medicine Hospital,Hubei Province,Jingmen 448000,China |
|
|
|
|
Abstract Objective To investigate the clinical effect of Polyethylene Glycol Eye Drops combined with Recombinant Bovine Basic Fibroblast Growth Factor Eye Gel in the treatment of meibomian gland dysfunction（MGD）xerophthalmia.Methods A total of 311 cases (622 eyes) of MGD patients with xerophthalmia who visited the outpatient department of Jingmen Traditional Chinese Medicine Hospital from April 2018 to July 2019 were selected as the research subjects.According to the random drawing method, the patients were divided into the observation group (160 cases, 320 eyes)and the control group (151 cases, 302 eyes).Two groups were treated with Recombinant Bovine Basic Fibroblast Growth Factor Eye Gel of conductance treatment, and the meibomian gland was mechanical dredged.The observation group was treated with Polyethylene Glycol Eye Drops 4 times/d, and the control group was treated with Polyethylene Glycol Eye Drops every other day.The patients′ self-conscious symptom score, Schirmer Ⅰtest (SⅠT), tear film rupture time(BUT), corneal fluorescein staining score and lipid trait score were compared between the two groups.Results There were no significant differences in BUT, corneal fluorescein staining and conscious symptom scores between the two groups before treatment (P>0.05).After treatment, BUT in the observation group was longer than that in the control group, and the corneal fluorescein staining and conscious symptom score in the observation group were lower than those in the control group, the differences were statistically significant (P＜0.05).After treatment, lipid trait scores of the two groups were lower than those before treatment, and the difference was statistically significant (P＜0.05).There was no significant difference in SⅠT between the two groups before and after treatment (P>0.05).There were no obvious adverse reactions in the two groups during the process of the treatment.Conclusion The clinical effect of standard Polyethylene Glycol Eye Drops combined with Recombinant Bovine Basic Fibroblast Growth Factor Eye Gel for the treatment of eyelid gland dysfunction type xerophthalmopathy is better and has high safety.
|
|
|
|
|
|
| [1] |
左春兰.干眼症治疗进展[J].中国校医，2018，32（9）：704-706.
|
| [2] |
刘泽源，李才锐.睑板腺功能障碍所致干眼的治疗[J].国际眼科杂志，2014，14（2）：270.
|
| [3] |
于春红，王云松.睑板腺功能障碍的治疗及研究进展[J].海南医学，2018，29（4）：531-534.
|
| [4] |
中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识（2013年）.中华眼科杂志2013，49（1）：73-75.
|
| [5] |
亚洲干眼协会中国分会,海峡两岸医药交流协会眼科专业委员会眼表与泪液病学组.我国睑板腺功能障碍诊断与治疗专家共识（2017年）[J].中华眼科杂志，2017，53（9）：657-661.
|
| [6] |
徐凤，王梅艳，李之忠，等.睑板腺管按摩联合药物治疗睑板腺功能障碍的临床疗效[J].国际眼科杂志，2017，17（11）：2164-2166.
|
| [7] |
吕孝平，杜诚，张永杰，等.中药眼罩熏蒸联合睑板腺按摩治疗睑板腺功能障碍型干眼症疗效观察[J].浙江中西医结合杂志，2018，28（2）：119-121.
|
| [8] |
The definition and classification of dry eye disease：report of the Definition and Classification Subcommittee of the International Dry Eye Work shop （2007）[J].Ocul surf，2007，5（2）：75-92.
|
| [9] |
魏庆华，王延召.睑板腺按摩联合人工泪液治疗睑板腺功能障碍型干眼症的临床观察分析[J].临床医药文献电子杂志，2020，7（41）：14-15.
|
| [10] |
刘祖国.干眼的临床诊断与治疗丞待规范化和精细化[J].中华眼科杂志，2017，53（9）：641-644.
|
| [11] |
张志红.聚乙二醇滴眼液联合重组牛碱性成纤维细胞生长因子治疗干眼症[J].国际眼科杂志，2013，13（4）：764-766.
|
| [12] |
Foley RN，Parfrey PS，Sarnak MJ.Epidemiology of cardiovascular disease in chronic renal disease[J].J Am Soc Nephrol，1998，9（12 Suppl）：S16-23.
|
| [13] |
Izumi S，Muano T，Mori A，et al.Common carotid artery stiffness，cardiovascular function and lipid metabolism after menopause[J].Life Sco，2012，78（15）：1696-1701.
|
| [14] |
王鑫.自拟逐瘀散结汤直流电离子导入治疗玻璃体积血的临床研究.世界中医药，2015，10（2）：1310-1311.
|
| [15] |
董玮，马莉珍.玻璃酸钠、卡波姆、聚乙二醇、妥布霉素地塞米松对比治疗青光眼合并白内障的临床观察[J].中国药房，2016，27（30）：4212-4214.
|
| [16] |
Craig JP，Nichols KK，Akpek EK，et al.TFOS DEWS Ⅱdefinition and classification report[J].Ocul Surf，2017，15（3）：276-283.
|
|
|
|
